Dr. Ulf Dahle is Specialist Director at the Norwegian Institute of Public Health and a microbiologist with extensive experience in infectious disease epidemiology, IPC, and AMR. His early research focused on the molecular epidemiology of tuberculosis, particularly the impact of migration on disease transmission, and included collaborations and expert assignments with international organizations such as WHO, ECDC, and NORAD. Since 2010, his work has increasingly focused on AMR, combining laboratory-based microbial characterization with broader public health perspectives, including behavioural, ethical, and system-level aspects of antimicrobial use and infection prevention. Dr. Dahle has held senior leadership roles in Norway’s national reference laboratory system and has led major institutional and national initiatives, including the establishment of sequencing-based reference laboratory platforms, modernization of microbiology infrastructure, and he also played a central role in Norway’s COVID-19 response as head of the national advisory hotline supporting healthcare services. He has authored numerous peer-reviewed publications on tuberculosis, AMR, microbial genomics, and antibiotic stewardship, and has contributed to national and international strategies addressing emerging infectious threats. His current work focuses on strengthening the integration of microbiology, IPC, and AMR strategies to support resilient healthcare systems and effective public health responses.